Duolan Naren
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Activation of the HMGB1-TLR4 pathway impacts the functionality of bone marrow mesenchymal stem cells and disrupts macrophage polarization in immune thrombocytopenia.
Journal: British journal of haematology
Published: April 28, 2024
Preclinical Short-term and Long-term Safety of Human Bone Marrow Mesenchymal Stem Cells.
Journal: Cell transplantation
Published: December 07, 2023
The short-term predictive value of CD4+ cells for combination therapy with high-dose dexamethasone and immunoglobulin in newly diagnosed primary immune thrombocytopenia patients.
Journal: Thrombosis research
Published: May 08, 2022
Homoharringtonine synergizes with quizartinib in FLT3-ITD acute myeloid leukemia by targeting FLT3-AKT-c-Myc pathway.
Journal: Biochemical pharmacology
Published: November 02, 2020
Positive expression of PAX7 indicates poor prognosis of pediatric and adolescent AML patients.
Journal: Expert review of hematology
Published: January 29, 2020
High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m6A methylation of MYC mRNA.
Journal: Journal of cancer research and clinical oncology
Published: March 09, 2019
High-expressing cystic fibrosis transmembrane conductance regulator interacts with histone deacetylase 2 to promote the development of Ph+ leukemia through the HDAC2-mediated PTEN pathway.
Journal: Leukemia research
Published: January 18, 2017
Niemann-Pick disease type C1(NPC1) is involved in resistance against imatinib in the imatinib-resistant Ph+ acute lymphoblastic leukemia cell line SUP-B15/RI.
Journal: Leukemia research
Published: October 30, 2015
The antileukemia effect of metformin in the Philadelphia chromosome-positive leukemia cell line and patient primary leukemia cell.
Journal: Anti-cancer drugs
Published: July 18, 2015
Last Updated: 09/26/2026